期刊文献+

肠溶型阿司匹林与普通阿司匹林临床中肠胃道不良反应的分析 被引量:6

Analysis of the Adverse Reactions Caused by Clinical Application of Aspirin Enteric-coated Tablets and Regular Aspirin Tablets
下载PDF
导出
摘要 目的探讨阿司匹林肠溶片与阿司匹林普通片剂在临床应用不良反应的差异。方法整群选取2012年3月—2015年1月该院收治的132例患者按照用药种类分为普通阿司匹林片组(60例)和阿司匹林肠溶片组(72例)的患者进行临床资料统计以及分析比较不良反应。结果两种药物在临床上的不良反应以胃肠道刺激所致不良反应多见。阿司匹林肠溶片组出现腹胀以及上腹不适等胃肠道不良反应的几率为2.78%,显著低于普通阿司匹林片组的16.67%,两组比较差异有统计学意义(P<0.05)。结论临床上长期使用阿司匹林肠溶片更安全性,所引起的不良反应与普通阿司匹林片相比更少。 Objective To compare the adverse reactions caused by clinical application of aspirin enteric-coated tablets and regular aspirin tablets. Methods 132 patients admitted in our hospital from March 2012 to January 2015 were selected and divided into regular aspirin tablets group (60 cases) and aspirin enteric-coated tablets group (72 cases) according to the types of medication. The clinical data of the groups were counted. And adverse reactions occurred during the treatment were comprehensively compared and analyzed between the groups. Results Gastrointestinal irritation was the most common ad- verse reactions of aspirin enteric^-eoated tablets group and regular aspirin tablets group. The incidence of abdominal disten- sion and abdominal discomfort and other gastrointestinal adverse reactions in the aspirin enteric-coated tablets group was siguifieandy lower than that in the ordinary aspirin tablets group (2.78% vs 16.67%), and the difference between the two groups was statistically siguificant(P〈0.05). Conclusion Compared with regular aspirin tablets, long-term clinical use of as- pirin enteric-coated tablets is safer with less adverse reactions.
作者 门正昆 王英
出处 《中外医疗》 2015年第35期35-37,共3页 China & Foreign Medical Treatment
关键词 阿司匹林肠溶片 普通阿司匹林 不良反应 Aspirin enteric-coated tablets Regular aspirin tablets Adverse reactions
  • 相关文献

参考文献11

  • 1戴加哲,谢城.孟鲁司特联合布地奈德治疗小儿哮喘疗效的观察[J].求医问药(下半月刊),2012,10(3):364-364. 被引量:11
  • 2杨文彬.孟鲁司特与布地奈德雾化吸入治疗小儿哮喘持续发作疗效研究[J].中外医疗,2012,31(25):101-101. 被引量:13
  • 3Yue JR. [Clinical study of using aspirin at various times to reduce adverse reactions of alpha-IFN][J].Zhonghua hu li za zhi, 1998,32(9):505-506.
  • 4孙德臣.浅谈拜阿司匹林在心脑血管疾病防治中的作用[J].中外女性健康,2014,0(10X):90-90. 被引量:2
  • 5杨雪峰,邓勇志.阿司匹林局部干预防治移植静脉血栓和新生内膜增生[J].中华临床医师杂志(电子版),2012,6(12):226-230. 被引量:3
  • 6McAlindon ME, Muller AF, Filipow icz B, et al. Effect of al- lopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers [J].Gut, 1996,38: 518-524.
  • 7S cheiman JM, Tillner A, Pohl T, et al. Reduction of non- steroidal anti-inflammatory drug induced gastric injury and leucocyte endothelial adhesion by octreotide[J].Gut,1997,40: 720-725.
  • 8Misra UK, Kalita J, Nair PP.Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial[J]. Journal of the Neurological Sciences,2010,293(2):12-17.
  • 9Petes ILl, M ehta SR, Fox KA, et al. Effects of aspirin done when use do alone or incombination with clopidogrel in pa- tients with ACS; Observations from the clopidogrel in Un- stable Angina to prevent Recurrent Events (CURE) study[J]. Circulaion, 2003,108(14):1682-1687.
  • 10Blondon H,Barbier JP,Mahe I,et al.Gastroduodenal tolera- bility of medium dose enteric-coated aspirin:a placebo controlled eddoscopic study of a new enteric-coated formu- lation s.regilar formulation in heahy volunteers[J].Fundam clin pharmacol, 2000,14(2):155-157.

二级参考文献27

  • 1陈伟熹,邓永超.布地奈德联合孟鲁司特雾化吸入治疗哮喘的临床疗效观察[J].中外健康文摘,2010,35(7):354-355.
  • 2景志豪.孟鲁司特联合布地奈德气雾剂治疗小儿轻度持续哮喘的临床疗效[J].心理医生(上半月),2011(9):147-148.
  • 3Christus T,Shukkur AM,Rashdan I. Coronary artery disease in patients aged 35 or less-A different beast[J].Heart Views,2011.7-11.
  • 4Semsroth S,Stigler RG,Bernecker OY. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts[J].European Journal of Cardio-Thoracic Surgery,2009.515-520.
  • 5Toshida T,Kaestner KH,Owens GK. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury[J].Circulation Research,2008.1548-1557.
  • 6Badreldin A,Kroener A,Kamiya H. Effect of clopidogrel on perioperative blood loss and transfusion in coronary artery bypass graft surgery[J].Interactive Cardiovascular and Thoracic Surgery,2010.48-52.
  • 7Chen W,Chu Y,Zhu D. Perivascular gene transfer of dominant-negative N19RhoA attenuates neointimal formation via inhibition of TGF-beta1-Smad2 signaling in rats after carotid artery balloon injury[J].Biochemical and Biophysical Research Communications,2009.217-223.
  • 8Dotsenko O,Jahangiri M. Endogenous stem cells in patients undergoing coronary artery bypass graft surgery[J].European Journal of Cardio-Thoracic Surgery,2009.563-571.
  • 9Motwani JG,Topol EJ. Aortocoronary saphenous vein graft disease:pathogenesis,predisposition,and prevention[J].Circulation,1998.916-931.
  • 10Naito M,Stirk CM,Smith EB. Smooth muscle cell outgrowth stimulated by fibrin degradation products The potential role of fibrin fragment E in restenosis and atherogenesis[J].Thrombosis Research,2000.165-174.

共引文献24

同被引文献52

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部